Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Biopharma Inc (NASDAQ:TBPH)

14.61
Delayed Data
As of Aug 28
 +0.87 / +6.33%
Today’s Change
11.36
Today|||52-Week Range
29.99
-2.08%
Year-to-Date

Today’s Trading

Previous close13.74
Today’s open13.61
Day’s range13.61 - 14.63
Volume180,351
Average volume (3 months)215,859
Market cap$495.8M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-52.24%
Earnings growth (this year)+30.56%
Earnings growth (next 5 years)+9.62%
Revenue growth (last year)+5,071.68%
P/E ratioNM
Price/Sales40.54
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.06-0.50%
KPTIKaryopharm Therapeut...+0.18+1.29%
SPPISpectrum Pharmaceuti...+0.11+1.47%
SRNESorrento Therapeutic...+0.33+2.48%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$1.33
Annual revenue (last year)$11.7M
Annual profit (last year)-$237.0M
Net profit margin-2,028.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
George Town, George Town

Forecasts

Partner Offers